Health
Study shows Oxford Covid vaccine has less protection against South African variant – The Guardian
Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death
The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines focus needs to shift from population immunity to protecting individuals from hospitalisation and death.
The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax…
-
General24 hours agoAuthorities say charged man used false name to escape from Perth court
-
Noosa News24 hours agoSkybound Gymnastics owner and coach Wei Jun Lee charged with sexual assault of teenager
-
Noosa News22 hours agoChild sex offenders to be known in Queensland public registry
-
General22 hours agoThousands flood cities demanding action on Palestine